Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2006
05/04/2006WO2006021894A3 Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells
05/04/2006WO2006019926A3 Inhibition of biofilm formation
05/04/2006WO2006012221A3 Target cell-specific short interfering rna and methods of use thereof
05/04/2006WO2006005043A3 Compositions and methods for detecting protein interactions with target dna sequences
05/04/2006WO2006004675A3 Production of tissue factor in plants
05/04/2006WO2006003018A3 Biologically safe transient protein expression in plants
05/04/2006WO2006002438A3 Human monoclonal antibodies to fc gamma receptor i (cd64)
05/04/2006WO2006000719A3 COG47 PROTEIN AND S100β GENE POLYMORPHISM
05/04/2006WO2005121174A3 Novel g-csf polypeptides, polynucleotides, modulators thereof, and methods of use
05/04/2006WO2005118628A3 Nucleic acid molecules encoding plant cyclotide polypeptides and methods of use
05/04/2006WO2005117974A3 Cancer treatment method by inhibiting mage gene expression or function
05/04/2006WO2005117950A3 Regulation of glucose and insulin levels by gnt-4 glycosyltransferase activity
05/04/2006WO2005116224A3 Tetracycline-regulated adeno-associated viral (aav) vectors for gene delivery to the nervous system
05/04/2006WO2005116069A3 Taste receptors of the t1r family from domestic dog
05/04/2006WO2005113606A3 Fgf-21 fusion proteins
05/04/2006WO2005113016A3 Modulation of glucose-6-phosphatase translocase expression
05/04/2006WO2005103301A3 Corn event mir604
05/04/2006WO2005103074A3 Combinatorial protein library screening by periplasmic expression
05/04/2006WO2005033694A8 Novel antisense oligomers and use thereof
05/04/2006WO2005033285A3 GENE MODULATION BY RB2/p130 EXPRESSION
05/04/2006WO2005021719A3 Libraries of recombinant chimeric proteins
05/04/2006WO2005019418A3 Modulation of diacylglycerol acyltransferase 2 expression
05/04/2006WO2005007805A3 ANTISENSE ANTIVIRAL AGENT AND METHOD FOR TREATING ssRNA VIRAL INFECTION
05/04/2006WO2004093783A3 Modulation of apolipoprotein c-iii expression
05/04/2006WO2004037972A3 Endogenous retrovirus up-regulated in prostate cancer
05/04/2006WO2003031937A3 Genetic hypermutability of plants for gene discovery and diagnosis
05/04/2006US20060095992 Wheat plants having increased resistance to imidazolinone herbicides
05/04/2006US20060095989 Carotenoids rich paprika cultivars
05/04/2006US20060095988 Synthetic plant genes and method for preparation
05/04/2006US20060095987 Methods and materials for conferring resistance to pests and pathogens of plants
05/04/2006US20060095986 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof
05/04/2006US20060095985 Modified plants
05/04/2006US20060095984 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
05/04/2006US20060095982 Phytoremediation of contaminant compounds via chloroplast genetic engineering
05/04/2006US20060095981 Transformation of a C3 plant cell with one or more nucleic acids encoding glycolate oxidase, glycolate dehydrogenase, glyoxylate carboligase, or tartronic semialdehyde reductase; trangenic plants, tissues, and cells
05/04/2006US20060095980 Depletion of endogenous primordial germ cells in avian species
05/04/2006US20060095979 Transgenic mice containing CLCN4 chloride ion channel gene disruptions
05/04/2006US20060095978 Screening assay
05/04/2006US20060094868 System for cell-based screening
05/04/2006US20060094864 Novel polypeptides and nucleic acid molecules encoding those polypeptides; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides fused to heterologous polypeptide sequences, and antibodies which bind to the polypeptides
05/04/2006US20060094863 Nucleic acid capable of hybridizing, serving as a marker for diagnosing feline nephropathy
05/04/2006US20060094678 Drug delivery of nucleotide into tumor; antitumor biodrugs; stability in cells; prevent gene expression of target genes
05/04/2006US20060094677 Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics
05/04/2006US20060094675 Method for the repair of mutated RNA from genetically defective DNA and for the specific destruction of tumor cells by RNA trans-splicing, and a method for the detection of naturally trans-spliced cellular RNA
05/04/2006US20060094117 Plasmid-free clone of e. coli strain dsm 6601
05/04/2006US20060094116 High-efficiency wild-type-free AAV helper functions
05/04/2006US20060094111 DNA containing variant FRT sequences
05/04/2006US20060094103 Modified BACE
05/04/2006US20060094102 Ammonium transporter promoter for gene expression in oleaginous yeast
05/04/2006US20060094095 Method and circuit arrangement for treating biomaterial
05/04/2006US20060094092 Oleaginous yeast Yarrowia lipolytica capable of producing greater than 10% arachidonic acid (ARA, an omega -6 polyunsaturated fatty acid) in the total oil fraction; desaturase
05/04/2006US20060094091 nucleic acid fragment isolated from fungi, that code for transferase enzymes, used in the manufacture of oils enriched in omega fatty acids in microorganisms such as algae, bacteria, fungi or yeasts; genetic engineering
05/04/2006US20060094090 Mortierella alpina lysophosphatidic acid acyltransferase homolog for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms
05/04/2006US20060094088 Acyltransferase regulation to increase the percent of polyunsaturated fatty acids in total lipids and oils of oleaginous organisms
05/04/2006US20060094087 Mortierella alpina diacylglycerol acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms
05/04/2006US20060094086 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms
05/04/2006US20060094085 Process and materials for production of glucosamine
05/04/2006US20060094080 DNA sequence encoding enzyme obtained from filamentous fungi; fermenting cell transformed with polypeptide
05/04/2006US20060094079 Protein for blocking platelet adhesion
05/04/2006US20060094078 Expressing an uncoupled ATPase activity in a cell; conversion of ATP to ADP without primary effects on other cellular metabolites or functions, and incubating the cell with a sugar; increasing the conversion rate of the sugar
05/04/2006US20060094061 Drug screening for inhibititors of extracellular matrix (ECM) degradation and inflammation using polypeptide and fragments, expression inhibitory agents such as antisense polynucleotide, a ribozyme, and a small interfering RNA; measuring binding affinity; arthritis; matrix metalloprotease, cathepsin
05/04/2006US20060094055 RNA silencing in animals as an antiviral defense
05/04/2006US20060094050 High fidelity reverse transcriptases and uses thereof
05/04/2006US20060094047 Primer for use in amplifying nucleotide sequences coding odor membrane protein
05/04/2006US20060094043 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
05/04/2006US20060094041 Oligonucleotide and method for detecting verotoxin
05/04/2006US20060094040 Lithographic mask design and synthesis of diverse probes on a substrate
05/04/2006US20060094032 iRNA agents targeting VEGF
05/04/2006US20060094030 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
05/04/2006US20060094026 Nucleic acid enzyme light-up sensor utilizing invasive DNA
05/04/2006US20060094015 Methods and materials for using chemical compounds as a tool for nucleic acid storage on media of nucleic acid purification systems
05/04/2006US20060094012 Polymorphisms for predicting disease and treatment outcome
05/04/2006US20060094007 Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc
05/04/2006US20060094005 Contacting the sample solution with a dipstick to cause sample solution to move by capillary action to a capture zone of the dipstick thereby allowing target nucleic acid in the sample solution to be captured and detected at the capture zone
05/04/2006US20060093661 Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
05/04/2006US20060093626 Lyophilization; conjugated Streptococcus pneumoniae capsular polysaccharide serotype is adjuvanted with 3-0 deacylated monophosphoryl lipid A (3D-MPL) and devoid of aluminium-based adjuvant
05/04/2006US20060093620 Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods
05/04/2006US20060093614 Platelet glycoprotein Ib alpha fusion polypeptides and methods of use thereof
05/04/2006US20060093613 Soluble T cell receptor
05/04/2006US20060093611 from mammalian chondrocyte progenitor cells expressing mechanosensitive TWIK-related potassium (TREK) ion channels; biocompatability, in vitro
05/04/2006US20060093610 Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS 06 of pseudomonas aeruginosa
05/04/2006US20060093604 Method of treatment and prophylaxis
05/04/2006US20060093603 ErbB4 antagonists
05/04/2006US20060093600 Antibodies to CD40
05/04/2006US20060093596 Genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish
05/04/2006US20060093590 Pseudotyped retroviruses
05/04/2006US20060093589 Vp2-modified raav vector compositions and uses therefor
05/04/2006US20060093587 Transplants for myocardial scars
05/04/2006US20060093585 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome
05/04/2006US20060093584 Intravascular delivery of nucleic acid
05/04/2006US20060093579 Human recombinant beta-interferon with improved solubility
05/04/2006US20060093575 Oxaliplatin anti-resistance agent
05/04/2006US20060092760 Device for mixing and/or injecting cements
05/04/2006DE19824900B4 DNA-Nachweis über einen Strangreassoziationskomplex DNA evidence of a Strangreassoziationskomplex
05/04/2006DE10320602B4 Verfahren zur Identifizierung einer möglichen Modifikation von mindestens einem biologischen Parameter unter Verwendung von jungen und alten lebenden Zellen A method for identifying a possible modification of at least one biological parameters using young and old living cells
05/04/2006DE10032254B4 Nukleotidsequenz kodierend für eine Benzaldehyd-Lyase und Verfahren zur stereoselektiven Synthese von (R)-2-Hydroxyketonen Nucleotide sequence encoding a benzaldehyde lyase and methods for the stereoselective synthesis of (R) -2-hydroxy ketones
05/04/2006CA2820140A1 Chlamydia trachomatis antigens for vaccine and diagnostic use
05/04/2006CA2592351A1 Transcriptional inhibitor for human k-ras gene
05/04/2006CA2588281A1 Plants having improved growth characteristics and method for making the same
05/04/2006CA2586182A1 Method of gene screening with yeast that inducibly expresses ergosterol biosynthetic enzyme